Assaf Moore, MD
We post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Areas of Expertise
Conditions I Treat
- Genitourinary cancers and conditions
- Prostate cancer and conditions
- Kidney (renal cell) cancer and conditions
My Specialties
- Brachytherapy
- Palliative radiation therapy
Get to Know Me
I am a radiation oncologist who specializes in radiation therapy for genitourinary and gynecological cancers including:
I also specialize in palliative radiotherapy, which uses radiation to help people, especially those with advanced disease, manage cancer symptoms and improve quality of life. I see patients at Memorial Hospital in Manhattan, and Memorial Sloan Kettering Commack and Memorial Sloan Kettering Nassau on Long Island.
After completing my residency in Israel, I trained at Memorial Sloan Kettering Cancer Center (MSK), where I gained expertise in advanced radiation techniques such as intensity-modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and brachytherapy, with the goal of achieving the best outcomes and minimizing side effects.
Throughout my career, I have had the privilege of working with multidisciplinary teams to deliver personalized, evidence-based treatment for patients with different types of genitourinary and gynecological cancers.
I am committed to providing innovative, patient-centered care, which aligns perfectly with my professional values and passion for cancer care. Each patient’s journey is unique, and I am committed to creating a supportive environment where they feel heard, respected, and actively involved in their care decisions.
I'm a radiation oncologist, which is a cancer doctor with special training in using radiation therapy (RT) to treat cancer.
- Assistant Attending Radiation Oncologist
Conditions I Treat
- Genitourinary cancers and conditions
- Prostate cancer and conditions
- Kidney (renal cell) cancer and conditions
- Bladder cancer
- Gynecologic cancers and conditions
- Cervical cancers and conditions
- Uterine cancers and conditions
My Specialties
- Brachytherapy
- Palliative radiation therapy
Education
- MD, Tel Aviv University School of Medicine, Israel
Residencies
- Radiation Oncology, Department of Radiation Oncology
- Davidoff Cancer Center, Beilinson Hospital, Israel
Fellowships
- Brachytherapy Fellowship, Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center
- Image-Guided Radiation Therapy (IGRT) Fellowship, Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
HMO, EPO PPO, POS, Transplant
In Network Coverage Type
PPO
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
PPO, HMO
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
Supplemental
In Network Coverage Type
PPO, POS, HMO
In Network Coverage Type
POS, EPO, HMO
In Network Coverage Type
State Government
In Network Coverage Type
State Government
In Network Coverage Type
PPO, POS, EPO, HMO
Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO, HMO
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
HMO, EPO
Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
State Government
In Network Coverage Type
EPO, HMO, PPO, POS
Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO EPO
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
TBD
In Network Coverage Type
PPO, POS, EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
HMO
City Employee Health Plans (Gold and Gold Care)
In Network Coverage Type
Supplemental
In Network Coverage Type
PPO/OAP
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
HMO/EPO
In Network Coverage Type
PPO, EPO
In Network Coverage Type
State Government
In Network Coverage Type
PPO, POS, HMO
In Network Coverage Type
PPO, HMO
In Network Coverage Type
PPO, POS
In Network Coverage Type
PPO, POS, HMO
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment
Contact and Location
Looking to see a doctor at a different location? See all MSK locations.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
- Washington C, Goldstein DA, Moore A, Gardner U Jr, Deville C Jr. Health Disparities in Prostate Cancer and Approaches to Advance Equitable Care. Am Soc Clin Oncol Educ Book. 2022 Apr;42:1-6. doi: 10.1200/EDBK_350751. PMID: 35671436.
- Moore A, Kollmeier MA, McBride SM, Toumbacaris N, Zhang Z, Lacy-Elsayegh A, Dreyfuss A, Grossman CE, Gorovets D, Zelefsky MJ. Long-term Outcomes from a Phase 1 Dose Escalation Study Using Stereotactic Body Radiotherapy for Patients with Low- or Intermediate-risk Prostate Cancer. Eur Urol Oncol. 2024 Aug;7(4):812-820. doi: 10.1016/j.euo.2023.10.019. Epub 2023 Nov 10. PMID: 37949730.
- Moore A, Zhang Z, Fei T, Zhang L, Accomando L, Schmitt AM, Higginson DS, Mueller BA, Zinovoy M, Gelblum DY, Yerramilli D, Xu AJ, Brennan VS, Guttmann DM, Grossman CE, Dover LL, Shaverdian N, Pike LRG, Cuaron JJ, Dreyfuss A, Lis E, Barzilai O, Bilsky MH, Yamada Y. 40 Gray in 5 Fractions for Salvage Reirradiation of Spine Lesions Previously Treated With Stereotactic Body Radiotherapy. Neurosurgery. 2024 Aug 1;95(2):380-391. doi: 10.1227/neu.0000000000002889. Epub 2024 Mar 8. PMID: 38456696.
- Moore A, Lobaugh SM, Zhang Z, Rosenberg JE, Iyer G, Teo MY, Bochner B, Donahue T, Nunez DA, Dreyfuss A, Gorovets D, Zelefsky MJ, Kollmeier MA. Hypofractionated Radiation Therapy (Hypo-RT) for the Treatment of Localized Bladder Cancer. Bladder Cancer. 2023 Jun 27;9(2):141-150. doi: 10.3233/BLC-220121. PMID: 38993294; PMCID: PMC11181850.
- Moore A, Yust-Katz S, Icht O, Eliyahou R, Gordon N, Cohen AY, Goldstein IM, Peled N, Seigal T, Amiel A, Dudnik E. Bevacizumab for stereotactic radiosurgery-induced radiation necrosis in patients with non-small cell lung cancer treated with immune check-point inhibitors. J Neurol Sci. 2021 Aug 15;427:117556. doi: 10.1016/j.jns.2021.117556. Epub 2021 Jun 24. PMID: 34186494.
Visit PubMed for a full listing of Dr. Moore’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
Disclosures
Members of the MSK Community often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community. These activities outside of MSK further our mission, provide productive collaborations, and promote the practical application of scientific discoveries.
MSK requires doctors, faculty members, and leaders to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public. Not all disclosed interests and relationships present conflicts of interest. MSK reviews all disclosed interests and relationships to assess whether a conflict of interest exists and whether formal COI management is needed.
Assaf Moore discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2024 through disclosure submission in spring 2025). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at ecoi@mskcc.org.